TG Therapeutics, Inc.【TGTX】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 3Q11 4Q11 1Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 - - - - - - - - - - - - - - - - - - - - - - - - - - 38 38 38 38 38 38 38 38 38 38 38 793 1,545 2,030 2,321 2,016 594 94 80 7,803 16,074 165,815 43,971 63,474 73,466 83,879 108,185 120,856 141,148 161,709 192,574
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 146.0 90.4 92.1 92.8 78
売上原価 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 139 - - - - - - - - - 3,509 7,854 5,441 8,304 9,341 15,399 15,541 18,938 28,093 38,142
研究開発費 95 -215 16,741 1,560 1,407 1,569 5,027 3,309 3,755 4,409 6,848 13,691 15,136 9,617 11,261 11,574 15,254 11,617 13,533 21,797 22,283 22,681 26,705 27,149 25,996 35,018 38,700 33,398 52,276 32,385 32,866 57,985 30,943 36,022 36,449 50,464 42,961 63,094 44,871 51,967 62,646 48,042 26,874 20,801 29,635 15,870 28,122 14,753 17,449 32,722 17,556 20,138 23,874 46,362 31,782 40,878 41,193
販売管理費 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 26,762 34,017 34,899 32,412 20,609 12,638 14,254 22,504 28,068 30,715 32,769 31,153 34,581 38,790 41,966 38,963 50,331 55,585 63,373 62,745
営業費用 - - 17,385 2,714 4,591 3,752 6,666 4,685 35,809 7,643 11,993 17,477 18,759 14,640 17,149 13,863 17,678 14,030 16,061 24,963 24,066 27,704 28,463 31,623 31,072 40,615 44,383 34,366 54,188 34,727 35,582 60,899 37,998 50,283 50,883 85,760 86,820 89,995 79,036 87,158 95,268 68,888 39,535 35,057 52,142 44,795 60,748 51,031 56,456 72,744 64,650 71,445 78,236 112,234 106,305 132,344 142,080
営業利益 -262 268 -17,386 -2,715 -3,691 -3,715 -6,629 -4,648 19,801 -7,606 -11,956 -17,440 -18,722 -14,603 -17,112 -13,826 -17,641 -13,993 -16,024 -24,926 -24,029 -27,667 -28,426 -31,586 -31,035 -41,577 -44,345 -34,328 -54,150 -34,689 35,544 -60,861 -37,961 -50,245 -50,845 -85,722 -86,782 -89,202 -77,492 -85,128 -92,947 -66,872 -38,941 -34,963 -52,062 -36,992 -44,674 114,784 -12,485 -9,270 8,816 12,434 29,949 8,622 34,843 29,365 50,494
営業利益率 (%) - - - - - - - - - - - - - - - - - - - - - - - - - - 27.7 7.1 24.7 18.2 26.2
経常(税引前)利益 - - - - - -3,674 -6,585 -4,557 -32,406 -7,548 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -10,678 6,551 4,268 25,453 5,468 30,920 25,909 45,093
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -16.8 8.9 5.1 23.5 4.5 21.9 16.0 23.4
法人税等合計 - - - - - 0 0 0 -330 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 29 -328 388 2,122 408 2,700 -365,000 22,011
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 8.3 7.5 8.7 -1408.8 48.8
純利益 -552 -1,152 -10,257 -2,463 -2,607 -3,674 -6,585 -4,557 -24,590 -7,548 -11,987 -17,452 -18,797 -14,578 -17,104 -13,656 -17,612 -13,849 -15,900 -24,832 -23,675 -27,728 -28,354 -31,536 -30,860 -41,529 -44,142 -33,951 -53,860 -35,156 36,213 -61,930 -39,572 -51,116 -52,884 -87,163 -88,218 -90,628 -78,497 -85,637 -93,338 -69,013 -40,510 -35,818 -52,994 -39,232 -47,610 113,930 -14,416 -10,707 6,879 3,880 23,331 5,060 28,187 390,895 23,037
純利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - 21.6 4.2 20.0 241.7 12.0
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.3 -0.26 -0.38 -0.28 -0.34 0.8 -0.1 -0.07 0.05 0.03 - 0.03 0.19 2.69 0.2
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.3 -0.26 -0.38 -0.28 -0.34 0.73 -0.1 -0.07 0.04 0.02 - 0.03 0.17 2.43 0.15
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 29,958 8,630 34,856 29,382 50,515
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 27.7 7.1 24.7 18.2 26.2